FIELD: medicine; pharmaceuticals.
SUBSTANCE: group of inventions relates to the treatment of oesophageal cancer. Method of treating oesophageal cancer involves administering a therapeutically effective amount of compound I:
or a pharmaceutically acceptable salt thereof to patients, in need of treatment. Also disclosed are use of compound I or a pharmaceutically acceptable salt thereof for treating oesophageal cancer, using a pharmaceutical composition for treating oesophageal cancer, use of the oesophageal cancer treatment kit.
EFFECT: group of inventions provides effective treatment of oesophageal cancer and reduces the sum of diameters of target focuses in the patient.
32 cl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| APPLICATION OF A NEW TYROSINKINASE INHIBITOR, ANLOTINIBA, IN OSTEOSARCOMA AND CHONDROSARCOMA | 2019 |
|
RU2787235C2 |
| METHODS OF TREATING DISEASES AND DISORDERS ASSOCIATED WITH LSD1, LSD1 INHIBITORS | 2020 |
|
RU2826217C1 |
| COMBINATION TREATMENT | 2014 |
|
RU2666999C2 |
| PHARMACEUTICAL COMBINATIONS FOR TREATING A MALIGNANT TUMOR | 2017 |
|
RU2726367C2 |
| POLYMORPHIC FORMS OF ICOTINIB AND USES THEREOF | 2014 |
|
RU2710013C2 |
| TYPES OF COMBINATION THERAPY FOR TREATING CANCER | 2021 |
|
RU2816314C1 |
| NOVEL POLYMORPHIC FORMS OF ICOTINIB PHOSPHATE AND USES THEREOF | 2014 |
|
RU2712169C2 |
| COMBINATIONS INCLUDING EPOTHILONES, AND THEIR PHARMACEUTICAL APPLICATION | 2002 |
|
RU2375058C2 |
| POLYMORPHOUS FORMS OF ICOTINIB MALEATE AND USES THEREOF | 2014 |
|
RU2708079C2 |
| ANTICANCER PHARMACEUTICAL COMPOSITIONS AND METHOD OF TREATING BREAST CANCER | 2015 |
|
RU2581022C1 |
